newsfilter
← Latest News
PR Newswire·

Karyopharm to Report Second Quarter 2026 Financial Results on August 13, 2026

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will...